Hodgkin Lymphoma News and Research

RSS
AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

Drug used in stem cell therapy may protect against smoke-induced lung injury

Drug used in stem cell therapy may protect against smoke-induced lung injury

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Clinical trial targets metastatic colorectal cancer with new combination therapy

Clinical trial targets metastatic colorectal cancer with new combination therapy

Some tumors use two levels of protection against immune system, shows study

Some tumors use two levels of protection against immune system, shows study

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New insights into breast implant-associated anaplastic large-cell lymphoma

New insights into breast implant-associated anaplastic large-cell lymphoma

Researchers propose alternative treatment to target lymphoma signaling at its root

Researchers propose alternative treatment to target lymphoma signaling at its root

Gene-editing technology enhances T cell immunotherapies for treating cancer

Gene-editing technology enhances T cell immunotherapies for treating cancer

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

New guidelines offer recommendations for assessment, management of immunotherapy side effects

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

Scientists identifies new genetic changes that increase risk of developing Hodgkin lymphoma

Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials